Renee Tannenbaum

(Dr. Renee Tannenbaum Ph.D.)

Currently holds a position at Zogenix Inc

Positions

Position Company Period
Independent Director Zogenix Inc Jan. 1, 2017 -
Independent Director Sharps Compliance Corp Feb. 29, 2012 - Nov. 19, 2015
Director Zogenix Inc Feb. 10, 2015 - June 18, 2015
Renee Tannenbaum's trades of Cardiff Oncology Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-16 2024-12-12
B Purchase
10,000 +100.0%
3.42
USD 34,224 		10,000 +100.0% 3.42 USD 34,224
2024-05-17 2024-05-16
S Sale
2,000 -9.9%
63.87
USD 127,740 		2,000 -9.9% 63.87 USD 127,740
2022-09-19 2022-09-15
B Purchase
3,600 +56.2%
1.72
USD 6,192 		3,600 +56.2% 1.72 USD 6,192
2022-09-19 2022-09-15
B Purchase
6,400 +inf%
1.72
USD 10,976 		6,400 +inf% 1.72 USD 10,976
2021-11-30 2021-11-29
US Zogenix Inc (ZGNX)
S Sale
5,305 -14.0%
11.72
USD 62,175 		5,305 -14.0% 11.72 USD 62,175
2021-06-03 2021-06-01
US Zogenix Inc (ZGNX)
B Purchase
5,000 +15.2%
17.05
USD 85,248 		5,000 +15.2% 17.05 USD 85,248
2020-11-18 2020-11-17
US Zogenix Inc (ZGNX)
S Sale
15,000 -31.3%
20.74
USD 311,066 		15,000 -31.3% 20.74 USD 311,066
2019-03-08 2019-03-06
US Zogenix Inc (ZGNX)
S Sale
17,503 -26.8%
50.65
USD 886,474 		17,503 -26.8% 50.65 USD 886,474
// ... existing code ... // ... rest of the file ...